发明申请
US20050032783A1 Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
审中-公开
使用CGRP拮抗剂治疗和预防前列腺癌患者的热潮红
- 专利标题： Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
- 专利标题（中）： 使用CGRP拮抗剂治疗和预防前列腺癌患者的热潮红
-
申请号： US10881892申请日： 2004-06-30
-
公开(公告)号： US20050032783A1公开(公告)日： 2005-02-10
- 发明人: Henri Doods , Klaus Rudolf , Wolfgang Eberlein , Wolfhard Engel , Mats Hammar , Anna-Clara Spetz
- 申请人： Henri Doods , Klaus Rudolf , Wolfgang Eberlein , Wolfhard Engel , Mats Hammar , Anna-Clara Spetz
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim
- 优先权： EP03015335.7 20030707; EP03021802.8 20030926
- 主分类号： A61K31/00
- IPC分类号： A61K31/00 ; A61K31/4045 ; A61K31/422 ; A61K31/517 ; A61K31/5513 ; A61K45/06
摘要：
The invention relates to a method of treatment or prevention of hot flushes in men who underwent castration, e.g. due to androgen ablation treatment in prostate cancer therapy, comprising administration of an effective amount of a CGRP antagonist and/or of a CGRP release inhibitor to the patient, and to the use of said active compounds for the manufacture of a pharmaceutical composition intended to be used in this method.
信息查询
